Literature DB >> 2671518

Disseminated Aspergillus terreus infection in immunocompromised hosts.

K S Hara1, J H Ryu, J T Lie, G D Roberts.   

Abstract

Aspergillus terreus is ubiquitous in the environment but has rarely been found to be pathogenic. When recovered from clinical specimens, it is commonly considered a saprophyte. We report two cases of fatal disseminated A. terreus infection. The first patient was receiving corticosteroid therapy for immune thrombocytopenia when the condition developed, and the second patient was receiving immunosuppressive therapy after bone marrow transplantation for myelodysplasia. We also describe the frequency of recovery of A. terreus in our laboratory. The serious pathogenic potential of A. terreus in immunocompromised hosts should be recognized.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671518     DOI: 10.1016/s0025-6196(12)61749-2

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  10 in total

Review 1.  Bilateral Aspergillus endophthalmitis in a patient with chronic lymphocytic leukaemia.

Authors:  O de O Machado Od; R Gonçalves; E M Fernandes; W R Campos; F Oréfice; A L L Curi
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 2.  In vitro analyses, animal models, and 60 clinical cases of invasive Aspergillus terreus infection.

Authors:  William J Steinbach; John R Perfect; Wiley A Schell; Thomas J Walsh; Daniel K Benjamin
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

Review 3.  Aspergillus endocarditis and myocarditis in a patient with the acquired immunodeficiency syndrome (AIDS). A review of the literature.

Authors:  J N Cox; F di Dió; G P Pizzolato; R Lerch; N Pochon
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

4.  In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

Authors:  D A Sutton; S E Sanche; S G Revankar; A W Fothergill; M G Rinaldi
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

5.  Bilateral pulmonary aspergilloma caused by an atypical isolate of Aspergillus terreus.

Authors:  Z U Khan; M Kortom; R Marouf; R Chandy; M G Rinaldi; D A Sutton
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

6.  Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining.

Authors:  C Lass-Flörl; M Nagl; C Speth; H Ulmer; M P Dierich; R Würzner
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

7.  Effect of reduced oxygen on the antifungal susceptibility of clinically relevant aspergilli.

Authors:  Ulrike Binder; Elisabeth Maurer; Michaela Lackner; Cornelia Lass-Flörl
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

8.  Epidemiology of Aspergillus terreus at a university hospital.

Authors:  John W Baddley; Peter G Pappas; Anita C Smith; Stephen A Moser
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

9.  Activities of antifungal agents against yeasts and filamentous fungi: assessment according to the methodology of the European Committee on Antimicrobial Susceptibility Testing.

Authors:  Cornelia Lass-Flörl; Astrid Mayr; Susanne Perkhofer; Guido Hinterberger; Johann Hausdorfer; Cornelia Speth; Manfred Fille
Journal:  Antimicrob Agents Chemother       Date:  2008-08-11       Impact factor: 5.191

10.  Endocarditis and aortal embolization caused by Aspergillus terreus in a patient with acute lymphoblastic leukemia in remission: diagnosis by peripheral-blood culture.

Authors:  G Schett; B Casati; B Willinger; G Weinländer; T Binder; F Grabenwöger; W Sperr; K Geissler; U Jäger
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.